長期投資家のためのIR情報
バリュートレンド

【4979】OATアグリオ
農薬、肥料、バイオスティミュラント。
類似企業:
【業界1位】 日産化学
【売上同水準】 北興化学工業 サンケイ化学


東証プライム
化学
>
農薬
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2026.12 2026/08/10 Q2予 33,820 → 0.0% 0.0% 3,800 → 0.0% 0.0% 3,700 → 0.0% 0.0% 2,410 → 0.0% 0.0%
2026.12 2026/05/13 Q1予 33,820 → 0.0% 0.0% 3,800 → 0.0% 0.0% 3,700 → 0.0% 0.0% 2,410 → 0.0% 0.0%
2026.12 2026/02/12 当初予 33,820 - - - 3,800 - - - 3,700 - - - 2,410 - - -
2025.12 2026/02/12 実 31,950 ↑ +3.7% +3.7% 3,450 ↑ +3.9% +3.9% 3,583 ↑ +11.6% +11.6% 2,327 ↑ +11.3% +11.3%
2025.12 2025/11/10 Q3予 30,820 → 0.0% 0.0% 3,320 → 0.0% 0.0% 3,210 → 0.0% 0.0% 2,090 → 0.0% 0.0%
2025.12 2025/08/08 Q2予 30,820 → 0.0% 0.0% 3,320 → 0.0% 0.0% 3,210 → 0.0% 0.0% 2,090 → 0.0% 0.0%
2025.12 2025/05/14 Q1予 30,820 → 0.0% 0.0% 3,320 → 0.0% 0.0% 3,210 → 0.0% 0.0% 2,090 → 0.0% 0.0%
2025.12 2025/02/12 当初予 30,820 - - - 3,320 - - - 3,210 - - - 2,090 - - -
2024.12 2025/02/12 実 29,773 ↑ +1.6% +1.6% 3,114 ↓ -1.1% -1.1% 3,242 ↑ +8.1% +8.1% 2,077 ↑ +8.2% +8.2%
2024.12 2024/11/08 Q3予 29,300 → 0.0% 0.0% 3,150 → 0.0% 0.0% 3,000 → 0.0% 0.0% 1,920 → 0.0% 0.0%
2024.12 2024/08/09 Q2予 29,300 → 0.0% 0.0% 3,150 → 0.0% 0.0% 3,000 → 0.0% 0.0% 1,920 → 0.0% 0.0%
2024.12 2024/02/13 当初予 29,300 - - - 3,150 - - - 3,000 - - - 1,920 - - -
2023.12 2024/02/13 実 28,988 ↑ +1.7% +4.6% 3,766 ↓ -5.9% +17.7% 3,800 ↓ -6.2% +21.8% 2,488 ↓ -6.1% +18.5%
2023.12 2023/11/08 Q3予 28,500 → 0.0% +2.9% 4,000 → 0.0% +25.0% 4,050 → 0.0% +29.8% 2,650 → 0.0% +26.2%
2023.12 2023/08/08 Q2予 28,500 → 0.0% +2.9% 4,000 → 0.0% +25.0% 4,050 → 0.0% +29.8% 2,650 → 0.0% +26.2%
2023.12 2023/05/10 Q1予 28,500 ↑ +2.9% +2.9% 4,000 ↑ +25.0% +25.0% 4,050 ↑ +29.8% +29.8% 2,650 ↑ +26.2% +26.2%
2023.12 2023/02/10 当初予 27,700 - - - 3,200 - - - 3,120 - - - 2,100 - - -
2022.12 2023/02/10 実 26,960 ↑ +1.4% +15.9% 3,346 ↑ +0.8% +55.3% 3,385 ↓ -4.6% +66.7% 2,261 ↓ -1.7% +70.1%
2022.12 2022/11/09 Q3予 26,600 ↑ +4.7% +14.3% 3,320 ↑ +7.1% +54.1% 3,550 ↑ +10.9% +74.8% 2,300 ↑ +9.0% +73.1%
2022.12 2022/08/09 Q2予 25,400 ↑ +2.8% +9.2% 3,100 ↑ +23.6% +43.9% 3,200 ↑ +28.6% +57.6% 2,110 ↑ +29.4% +58.8%
2022.12 2022/05/11 Q1予 24,700 ↑ +6.2% +6.2% 2,509 ↑ +16.4% +16.4% 2,488 ↑ +22.5% +22.5% 1,631 ↑ +22.7% +22.7%
2022.12 2022/02/10 当初予 23,263 - - - 2,155 - - - 2,031 - - - 1,329 - - -
2021.12 2022/02/10 実 22,657 ↑ +2.1% +6.4% 1,982 ↑ +10.7% +24.3% 1,969 ↑ +13.2% +38.8% 1,443 ↑ +22.3% +58.9%
2021.12 2021/11/10 Q3予 22,200 → 0.0% +4.3% 1,790 → 0.0% +12.3% 1,740 → 0.0% +22.6% 1,180 → 0.0% +30.0%
2021.12 2021/08/10 Q2予 22,200 ↑ +4.3% +4.3% 1,790 ↑ +12.3% +12.3% 1,740 ↑ +22.6% +22.6% 1,180 ↑ +30.0% +30.0%
2021.12 2021/05/12 Q1予 21,288 → 0.0% 0.0% 1,594 → 0.0% 0.0% 1,419 → 0.0% 0.0% 908 → 0.0% 0.0%
2021.12 2021/02/12 当初予 21,288 - - - 1,594 - - - 1,419 - - - 908 - - -
2020.12 2021/02/12 実 20,288 ↑ +0.4% -6.8% 1,512 ↑ +2.2% +7.6% 1,346 ↑ +6.9% +6.9% 837 ↑ +9.1% +36.5%
2020.12 2021/01/29 修正予 20,210 ↓ -7.2% -7.2% 1,480 ↑ +5.3% +5.3% 1,259 → 0.0% 0.0% 767 ↑ +25.1% +25.1%
2020.12 2020/11/13 Q3予 21,779 → 0.0% 0.0% 1,405 → 0.0% 0.0% 1,259 → 0.0% 0.0% 613 → 0.0% 0.0%
2020.12 2020/08/14 Q2予 21,779 → 0.0% 0.0% 1,405 → 0.0% 0.0% 1,259 → 0.0% 0.0% 613 → 0.0% 0.0%
2020.12 2020/05/15 Q1予 21,779 → 0.0% 0.0% 1,405 → 0.0% 0.0% 1,259 → 0.0% 0.0% 613 → 0.0% 0.0%
2020.12 2020/02/14 当初予 21,779 - - - 1,405 - - - 1,259 - - - 613 - - -
2019.12 2020/02/14 実 21,909 ↓ -0.4% -4.7% 1,077 ↓ -1.5% -42.4% 837 ↑ +4.2% -50.1% 4 ↓ -93.0% -99.6%
2019.12 2019/12/17 修正予 21,996 ↓ -4.3% -4.3% 1,093 ↓ -41.5% -41.5% 803 ↓ -52.1% -52.1% 57 ↓ -94.3% -94.3%
2019.12 2019/11/14 Q3予 22,995 → 0.0% 0.0% 1,869 → 0.0% 0.0% 1,676 → 0.0% 0.0% 1,007 → 0.0% 0.0%
2019.12 2019/08/09 Q2予 22,995 → 0.0% 0.0% 1,869 → 0.0% 0.0% 1,676 → 0.0% 0.0% 1,007 → 0.0% 0.0%
2019.12 2019/05/13 Q1予 22,995 → 0.0% 0.0% 1,869 → 0.0% 0.0% 1,676 → 0.0% 0.0% 1,007 → 0.0% 0.0%
2019.12 2019/02/14 当初予 22,995 - - - 1,869 - - - 1,676 - - - 1,007 - - -
2018.12 2019/02/14 実 15,278 ↓ -0.1% -0.1% 1,762 ↓ -7.9% -7.9% 1,757 ↓ -7.3% -7.3% 1,257 ↓ -4.1% -4.1%
2018.12 2018/11/09 Q3予 15,290 → 0.0% 0.0% 1,913 → 0.0% 0.0% 1,895 → 0.0% 0.0% 1,311 → 0.0% 0.0%
2018.12 2018/08/10 Q2予 15,290 → 0.0% 0.0% 1,913 → 0.0% 0.0% 1,895 → 0.0% 0.0% 1,311 → 0.0% 0.0%
2018.12 2018/05/10 Q1予 15,290 → 0.0% 0.0% - - - - 1,895 → 0.0% 0.0% 1,311 → 0.0% 0.0%
2018.12 2018/02/09 当初予 15,290 - - - 1,913 - - - 1,895 - - - 1,311 - - -
2017.12 2018/02/09 実 14,118 ↑ +0.8% +4.6% 1,882 ↑ +4.6% +31.6% 1,890 ↑ +8.0% +34.1% 1,298 ↑ +18.0% +35.5%
2017.12 2017/11/10 Q3予 14,000 ↑ +3.7% +3.7% 1,800 ↑ +25.9% +25.9% 1,750 ↑ +24.2% +24.2% 1,100 ↑ +14.8% +14.8%
2017.12 2017/08/10 Q2予 13,496 → 0.0% 0.0% 1,430 → 0.0% 0.0% 1,409 → 0.0% 0.0% 958 → 0.0% 0.0%
2017.12 2017/05/10 Q1予 13,496 → 0.0% 0.0% 1,430 → 0.0% 0.0% 1,409 → 0.0% 0.0% 958 → 0.0% 0.0%
2017.12 2017/02/10 当初予 13,496 - - - 1,430 - - - 1,409 - - - 958 - - -
2016.12 2017/02/10 実 12,938 ↑ +3.5% +3.5% 1,611 ↑ +28.9% +28.9% 1,579 ↑ +26.8% +26.8% 950 ↑ +23.4% +23.4%
2016.12 2016/11/11 Q3予 12,500 → 0.0% 0.0% 1,250 → 0.0% 0.0% 1,245 → 0.0% 0.0% 770 → 0.0% 0.0%
2016.12 2016/08/10 Q2予 12,500 → 0.0% 0.0% 1,250 → 0.0% 0.0% 1,245 → 0.0% 0.0% 770 → 0.0% 0.0%
2016.12 2016/05/11 Q1予 12,500 → 0.0% 0.0% 1,250 → 0.0% 0.0% 1,245 → 0.0% 0.0% 770 → 0.0% 0.0%
2016.12 2016/02/10 当初予 12,500 - - - 1,250 - - - 1,245 - - - 770 - - -
2015.12 2016/02/10 実 12,129 ↑ +0.2% +3.1% 1,112 ↑ +1.1% +58.9% 1,105 ↑ +0.5% +64.2% 678 ↑ +9.4% +56.6%
2015.12 2015/11/10 修正予 12,100 ↑ +2.9% +2.9% 1,100 ↑ +22.2% +57.1% 1,100 ↑ +22.2% +63.4% 620 ↑ +24.0% +43.2%
2015.12 2015/08/07 Q2予 11,762 → 0.0% 0.0% 900 ↑ +28.6% +28.6% 900 ↑ +33.7% +33.7% 500 ↑ +15.5% +15.5%
2015.12 2015/05/11 Q1予 11,762 → 0.0% 0.0% 700 - - - 673 → 0.0% 0.0% 433 → 0.0% 0.0%
2015.12 2015/02/10 当初予 11,762 - - - - - - - 673 - - - 433 - - -
2014.12 2015/02/10 実 - - - - - - - - - - - - - - - -
2014.12 2014/11/10 Q3予 11,238 → 0.0% -6.4% 660 → 0.0% -47.1% 637 → 0.0% -47.7% 334 → 0.0% -55.8%
2014.12 2014/10/03 修正予 11,238 ↓ -6.4% -6.4% 660 ↓ -47.1% -47.1% 637 ↓ -47.7% -47.7% 334 ↓ -55.8% -55.8%
2014.12 2014/08/14 当初予 12,007 - - - 1,247 - - - 1,219 - - - 756 - - -
シェア ツイート
ページトップへ戻る